Oratect III 6 panel Multi drug test is an on-site multi drug test that uses oral fluid to detect the presence of up to 6 drugs. Oratect III Oral Multi-Drug Test is simple rapid and non-invasive one step Multi drug test procedure. Oratect III Oral Multi-Drug Test detects parent drugs instead of metabolites. Oratect III- Rapid 6 panel Multi Saliva Test device will indicate if the sample is negative or presumptive positive. If the Multi Drug Test is presumptive positive, further testing is indicated. It can be performed on-site and provides immediate answers. Oratect III Multi Drug Test is a one-step process. There is no sample handling or any instrumentation required. If there is a presumptive positive result, confirmation can be performed on the same sample. Oratect III Multi Drug Test has a lower concentration than most other drugs of abuse test. The lower cut-off levels mean the Oratect III Oral Multi-Drug Test will detect a larger number of drug users. Oratect III Oral Multi-Drug Test main feature is the convenience of oral fluid collection samples. Oratect III Oral Multi-Drug Test introduces the only one-step chromatographic immunoassay Oral Multi-Drug Test device for the qualitative detection of drugs of abuse in oral fluid. The on-site Multi Saliva Test allows testers to obtain the rapid results they need without having the concerns of handling urine specimens.

The Oratect III Multi Saliva Test allows for the collection and testing in one integrated device with user friendly and non invasive results in 5 minutes. The Oratect III Multi Saliva Test gives ease of both gender testing observation without the need for special facilities or gender-based observers and reduces the chances of sample adulteration. The Oratect III Multi Saliva Test is 99.9% accurate, easy to use and provides both large and small Companies a lower cost, less invasive alternative to lab based urine drugs of abuse testing while saving you test result costs and employee down time.

The Oratect III, Multi Saliva Test Screen Device is a one-step chromatographic immunoassay device for the qualitative simultaneous detection of multiple drugs. Oratect III Oral Fluid Test 6 panel saliva screen. The Oratect III, Oral Fluid Test 6 Panel Drug Screen introduces a blue line indicator for the sufficient collection of saliva. The presence or absence of a red line corresponding to a specific drug on the panel indicates a negative result or presumptive positive result respectively. This on-site saliva screen allows testers to obtain the rapid results they need without having the concerns of handling a urine specimen. Detecting drug use with an Oratect III, 6 Panel Oral Fluid Test is a clean and easy drug screening technique. The Oratect III Oral Fluid Test is designed and calibrated to be interpreted 5 minutes after starting the saliva collection procedure. Waiting longer than 10 minutes may result in erroneous results or false positive results.

The Oratect III Oral Fluid Test is designed for the qualitative detection of drugs of abuse in human saliva. It is a one-step lateral flow immunoassay device for the qualitative detection of drugs in human oral fluid. Illegal drugs contribute to many accidents, injuries and medical conditions. Screening individuals for drugs of abuse is an important method in identifying those who may cause harm to themselves and to others. Oratect III Oral Fluid Test is designed to integrate oral fluid collection and simultaneous testing for drugs-of-abuse. The Oratect III Multi Saliva Test Screen tests drug derivatives immobilized on the membrane compete with the drug(s) which may be present in the oral fluid for limited antibody binding sites on the colored colloidal gold antibody conjugate. During testing, saliva is collected at the collection pad and migrates across the membrane. This is indicated by the movement of the blue lines. If no drug is present in the oral fluid, the colored colloidal gold antibody conjugate will bind to the drug derivatives on the membrane to form visible bands at specific test regions.

Oratect III Saliva BZO